16 July 2018

ASX Announcement

Penthrox approved in Italy, The Czech Republic and Spain.

Medical Developments International Limited (ASX: MVP) is delighted to announce that Penthrox has been approved for sale in Italy, the Czech Republic and Spain.

MVP CEO, Mr. John Sharman said, 'We are delighted to have received the approval for these countries and we expect sales to commence in these markets during FY19. This leaves just two further European approvals pending - Luxembourg and Lithuania, with these approvals considered imminent.'

For the actual ASX announcements, please refer to the attached links -Penthrox approved in Italy and the Czech Republic and Penthrox approved in Spain

Attachments

  • Original document
  • Permalink

Disclaimer

Medical Developments International Limited published this content on 16 July 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 16 July 2018 02:24:02 UTC